Floyd Vivino, known to several generations of New York City-area fans (including more than a few rock stars) as local kids TV host Uncle Floyd, died Thursday, January 22, after suffering ill health ...

New Jersey comedian and pianist Floyd Vivino — best-known for starring in television’s “Uncle Floyd Show” has died at age 74, according to his family. “With a heavy heart I am sad to announce the ...

Floyd Vivino, best known as the beloved comedian, musician and TV personality "Uncle Floyd" who became a fixture in New Jersey culture, has died. He was 74. Jerry Vivino, Uncle Floyd's brother, shared ...

The family of Renee Nicole Good, the woman who was fatally shot by a U.S. Immigration and Customs Enforcement (ICE) agent last week in Minneapolis, is now represented by the firm who represented the ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

The Minneapolis City Council on Thursday evening approved a redesign plan for George Floyd Square, capping off years of planning, public input and debate. The council voted 9-4 to move forward with a ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Derek Chauvin, the ex-Minneapolis police officer convicted of second-degree murder in the killing of George Floyd, has filed an appeal requesting a new trial. Chauvin submitted the filing last month ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...